logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Scott Glaser

This inventor holds 19 USPTO granted patents and 8 published patent applications and 2 EPO patents, primarily in Immunotherapy Antibodies. Top assignees: Biogen Idec Ma Inc., Novartis Ag, Applied Molecular Evolution. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott Glaser. Retrieved from https://idiyas.com/inventor/scott-glaser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 57.9

 

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 188(Granted Patents)


Company Filing History:

goldMedal10 out of 216 
 
Biogen Idec Ma Inc.
 patents
silverMedal4 out of 3,978 
 
Novartis Ag
 patents
bronzeMedal2 out of 27 
 
Applied Molecular Evolution
 patents
4. 2 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
5. 1 out of 269 
 
Biogen Ma Inc.
 patents

Years Active: 1998-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-CCR7 Antibodies
mRNA-Mediated Immunization
Combination Therapies
Binding Molecules
Polypeptide Compositions
Cancer Treatment
Light Targeting Molecules
Mutant Antibodies
Therapeutic Antibodies
Stabilized Compositions
Purification Methods
Multispecific Antibodies
19 patents (USPTO):Explore Patents
1. 12180291 - Anti-CCR7 antibody drug conjugates (2024-12-31),
2. 11939397 - ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapies (2024-03-26),
3. 11878060 - mRNA-mediated immunization methods (2024-01-23),
4. 11634497 - Anti-CCR7 antibody drug conjugates (2023-04-25),
5. 9409950 - Linker peptides and polypeptides comprising same (2016-08-09),
6. 8892364 - Stabilized polypeptide compositions (2014-11-18),
7. 8734795 - Light targeting molecules and uses thereof (2014-05-27),
8. 8603473 - Modified binding molecules comprising connecting peptides (2013-12-10),
9. 8147829 - Anti-IGR-1R antibodies and uses thereof (2012-04-03),
10. 8084026 - Multispecific binding molecules comprising connecting peptides (2011-12-27),
11. 8021661 - Cripto binding molecules (2011-09-20),
12. 7960142 - Stabilized polypeptide compositions (2011-06-14),
13. 7951918 - Stabilized polypeptide compositions (2011-05-31),
14. 7700097 - Purification and preferential synthesis of binding molecules (2010-04-20),
15. 7612178 - Anti-IGF-1R antibodies and uses thereof (2009-11-03),

Title: The Inventor Scott Glaser: Pioneering Innovations in San Diego

Introduction: Scott Glaser is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Scott Glaser holds several patents in the fields of technology and healthcare, including a recent patent for a revolutionary medical device aimed at improving patient outcomes.

Career Highlights: With a career spanning over two decades, Scott Glaser has consistently pushed the boundaries of innovation, leading to significant advancements in his areas of expertise.

Collaborations: Throughout his career, Scott Glaser has collaborated with top researchers, engineers, and industry experts to bring his inventions to life, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Scott Glaser's passion for innovation and his dedication to improving the world through his inventions make him a standout figure in the inventor community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…